Showing results (101-110 of 194) with videos related to
Sort By:
Pageof 20
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2014
Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomesXiao-Dong Mo, Jun Kong, Ting Zhao, et al.Blood Cell Therapy|June 9, 2025
PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantationLing Ma, Si-Qi Li, Wei Han, et al.Clinical and Experimental Medicine|May 13, 2026
Ultra-Low BCR::ABL1 positivity by digital PCR does not improve post-transplant risk stratification beyond real-time PCR in Ph+ acute lymphoblastic leukemia post-transplantYa Luo, Wen-Min Chen, Xiao-Su Zhao, et al.HLA|June 10, 2022
Prevalence and risk factors of antibodies to HLA according to different cut-off values of mean fluorescence intensity in haploidentical allograft candidates: A prospective study of 3805 subjectsNing Ma, Jia-Pei Guo, Xiang-Yu Zhao, et al.Journal of Hematology & Oncology|February 8, 2017
The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemiaYa-Zhen Qin, Yu Wang, Lan-Ping Xu, et al.Journal of Hematology & Oncology|July 10, 2015
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation setsYing-Jun Chang, Xiang-Yu Zhao, Lan-Ping Xu, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2015
Epstein-Barr Virus-Related Post-Transplantation Lymphoproliferative Disorder after Unmanipulated Human Leukocyte Antigen Haploidentical Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment, and Clinical OutcomesLan-Ping Xu, Chun-Li Zhang, Xiao-Dong Mo, et al.Cellular & Molecular Immunology|January 12, 2022
Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantationXu-Ying Pei, Xue-Fei Liu, Xiang-Yu Zhao, et al.International Journal of Cardiology|June 26, 2012
Heart failure after allogeneic hematopoietic stem cell transplantationXiao-Dong Mo, Lan-Ping Xu, Dai-Hong Liu, et al.Blood Science (Baltimore, Md.)|November 24, 2025
Cerebrospinal fluid profile associated with the incidence and outcomes of patients with chronic graft-versus-host disease after haploidentical hematopoietic stem cell transplantationChen Zhao, Hai-Xia Fu, Xiao-Dong Mo, et al.Pageof 20